Skip to main content
. 2021 Jun 28;12:639872. doi: 10.3389/fgene.2021.639872

FIGURE 4.

FIGURE 4

The survival curves of two groups of patients who highly and lowly expressed ucoo2kmd.1, MIR155HG, lnc-HOXC4-3:1, and EFNA3, respectively. The patients were divided into two groups using the surv_cutpoint function of the survminer R package according to the gene expression levels, which were represented as “High-expression” and “Low-expression,” respectively. The red lines denote the relationship between survival time and overall survival for the patients in the “High-expression” group, and the blue lines represent the relationship between the survival time and the overall survival for the patients in the “Low-expression” group. (A) The survival curves of two groups of the breast cancer patients who highly and lowly expressed ucoo2kmd.1 gene, respectively; (B) The survival curves of two groups of the lung cancer patients who highly and lowly expressed MIR155HG gene, respectively; (C) The survival curves of two groups of the colorectal cancer patients who highly and lowly expressed lnc-HOXC4-3:1 gene, respectively. (D) The survival curves of two groups of the colorectal cancer patients who highly and lowly expressed EFNA3 gene, respectively.